Eagle Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference

Jefferies 2014 Global Healthcare Conference

WOODCLIFF LAKE, N.J.--()--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced today that the company will present at the Jefferies 2014 Global Healthcare Conference to be held June 2-5, 2014 at the Grand Hyatt in New York City.

Scott Tarriff, President and Chief Executive Officer, and David E. Riggs, Chief Financial Officer, will host the presentation on Thursday, June 5, 2014 at 8:30 a.m. EDT.

To listen to the live webcast of this presentation during the event, please visit: www.eagleus.com. A replay of this webcast will be available for 30 days after the initial presentation.

About Eagle

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing injectable products utilizing the FDA's 505(b)(2) regulatory pathway. The company develops products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. For further information: http://www.eagleus.com

Contacts

Eagle Pharmaceuticals, Inc.
David E. Riggs, 201-326-5300
Chief Financial Officer
driggs@eagleus.com

Sharing

Contacts

Eagle Pharmaceuticals, Inc.
David E. Riggs, 201-326-5300
Chief Financial Officer
driggs@eagleus.com